Published on 31 Aug 2022 on Zacks via Yahoo Finance
Shares of Aerie Pharmaceuticals AERI have skyrocketed in the past three months, outpacing other medical stocks in the industry after the company announced its acquisition deal with Alcon Pharmaceuticals ALC.
AERI shares have surged 137.5% in the past month against the industry’s decline of 2.6%.
Zacks Investment Research